tetano
Editor, Senior Moderator
J Infect Public Health
. 2022 Nov 11;15(12):1409-1414.
doi: 10.1016/j.jiph.2022.11.011. Online ahead of print.
Clinical characteristics and risks of the convalescent COVID-19 patients with re-detectable positive RNA test: a 430 patients with Omicron infected cross-sectional survey in Tianjin, China
Tianning Li[SUP] 1 [/SUP], Meng Han[SUP] 2 [/SUP], Jingyu Wang[SUP] 3 [/SUP], Chunlei Zhou[SUP] 4 [/SUP], Hong Mu[SUP] 5 [/SUP]
Affiliations
Abstract
Background: The outbreak of severe acute respiratory syndrome coronavirus (SARS-CoV-2) Omicron variant occurred in Tianjin, China, at the beginning of 2022. In the present study, we identified risk factors that may affect positive (RP) RNA re-testing in recovered patients infected with Omicron variants during recovery in hospital.
Methods: We retrospectively analyzed the medical records of 425 patients with Omicron variant infection admitted to our medical center from January 21, 2022 to February 24, 2022, based on the recurrence of RT-PCR positive results for SARS-CoV-2 after cure and discharge. Patients were divided into re-tested positive (RP) and non-re-detectable positive patients (NRP) groups, and clinical data from both groups were analyzed to investigate the characteristics and risk factors of RP patients.
Results: Univariate analysis showed significant differences in age, vaccination rate and dose, partial signs and symptoms, most co-existing disorders, and levels of CRP and IL-6 between the RP and NRP groups (all P < 0.05), while multifactorial logistic regression analysis showed that vaccination status and levels of IL-6 were independent risk factors for RP patients.
Conclusion: Our results suggested that clinicians should assess the probability of "re-positive" nucleic acid tests after discharge, taking the following indicators into account: pre-admission underlying diseases, unvaccinated status, and high levels of CRP and IL-6. Post-discharge isolation and follow-up should also be strengthened.
Keywords: COVID-19; Omicron; SARS-CoV-2; The re-detectable positive RNA test.
. 2022 Nov 11;15(12):1409-1414.
doi: 10.1016/j.jiph.2022.11.011. Online ahead of print.
Clinical characteristics and risks of the convalescent COVID-19 patients with re-detectable positive RNA test: a 430 patients with Omicron infected cross-sectional survey in Tianjin, China
Tianning Li[SUP] 1 [/SUP], Meng Han[SUP] 2 [/SUP], Jingyu Wang[SUP] 3 [/SUP], Chunlei Zhou[SUP] 4 [/SUP], Hong Mu[SUP] 5 [/SUP]
Affiliations
- PMID: 36395665
- DOI: 10.1016/j.jiph.2022.11.011
Abstract
Background: The outbreak of severe acute respiratory syndrome coronavirus (SARS-CoV-2) Omicron variant occurred in Tianjin, China, at the beginning of 2022. In the present study, we identified risk factors that may affect positive (RP) RNA re-testing in recovered patients infected with Omicron variants during recovery in hospital.
Methods: We retrospectively analyzed the medical records of 425 patients with Omicron variant infection admitted to our medical center from January 21, 2022 to February 24, 2022, based on the recurrence of RT-PCR positive results for SARS-CoV-2 after cure and discharge. Patients were divided into re-tested positive (RP) and non-re-detectable positive patients (NRP) groups, and clinical data from both groups were analyzed to investigate the characteristics and risk factors of RP patients.
Results: Univariate analysis showed significant differences in age, vaccination rate and dose, partial signs and symptoms, most co-existing disorders, and levels of CRP and IL-6 between the RP and NRP groups (all P < 0.05), while multifactorial logistic regression analysis showed that vaccination status and levels of IL-6 were independent risk factors for RP patients.
Conclusion: Our results suggested that clinicians should assess the probability of "re-positive" nucleic acid tests after discharge, taking the following indicators into account: pre-admission underlying diseases, unvaccinated status, and high levels of CRP and IL-6. Post-discharge isolation and follow-up should also be strengthened.
Keywords: COVID-19; Omicron; SARS-CoV-2; The re-detectable positive RNA test.